Thomas Dyrberg serves as Executive at BIOMIMETIC THERAPEUTICS, INC., where they oversee executive responsibilities. Since joining the company, Thomas Dyrberg has executed 6 insider transactions totaling $4.2M, demonstrating a bullish approach to their equity position. Their most recent transaction on Sep 30, 2013 involved purchasing 700 shares valued at $15.4K.
Thomas Dyrberg currently holds 700 shares of BIOMIMETIC THERAPEUTICS, INC. (BMTI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Thomas Dyrberg has been a net buyer of BMTI stock. They have purchased $4.2M and sold $0 worth of shares.
Thomas Dyrberg's most recent insider trade was on Sep 30, 2013, when they purchased 700 shares at $22.00 per share.
Get notified when new Form 4 filings are submitted
| $12.46 |
| Discretionary |
| Nov 23, 2006 | BMTI | $0 | Other | 343,574 | $N/A | Discretionary |
| May 11, 2006 | BMTI | $0 | Conversion | 738,174 | $N/A | Discretionary |
| May 11, 2006 | BMTI | $0 | Conversion | 758,097 | $N/A | Discretionary |
| May 11, 2006 | BMTI | $0 | Conversion | 196,351 | $N/A | Discretionary |